TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24067537

Group type: EXPERIMENTAL
Intervention: Serum resistin levels in PAD patients
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Serum resistin levels in PAD subgroups
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: hsCRP levels in PAD patients
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: hsCRP levels among PAD subgroups
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ln-resistin levels correlation with ankle-brachial pressure index
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ln-resistin levels correlation with total cholesterol levels
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ln-resistin as a risk factor for PAD
Number of subjects: 200
Study: 21572992

Group type: EXPERIMENTAL
Intervention: Adrenaline (0.25 ml of a 1:1,000 solution subcutaneously)
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (200 mg intravenously)
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg intravenously)
Number of subjects: 1007

Group type: EXPERIMENTAL
Intervention: Adrenaline + Hydrocortisone
Number of subjects: 1007

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1007
Study: 19191844

Group type: EXPERIMENTAL
Intervention: Therapeutic horse riding (10-week program)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Therapeutic horse riding
Number of subjects: 99
Study: 16790616

Group type: EXPERIMENTAL
Intervention: Methylene blue (MB) 3 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (S)
Number of subjects: 30
Study: 12627741

Group type: EXPERIMENTAL
Intervention: Enhanced intervention conditions
Number of subjects: 265

Group type: COMPARATOR
Intervention: National Institute on Drug Abuse standard condition
Number of subjects: 265
Study: 10696738

Group type: EXPERIMENTAL
Intervention: Concurrent intra-arterial infusion of platinum drugs with radiation therapy (IAPRT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 33
Study: 8629920

Group type: EXPERIMENTAL
Intervention: Use of a cane in the nondominant hand
Number of subjects: 16

Group type: COMPARATOR
Intervention: No cane (control condition)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Use of a cane in the contralateral nondominant hand
Number of subjects: 16

Group type: COMPARATOR
Intervention: No visual feedback
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inversion perturbation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cane forces
Number of subjects: 16
Study: 6388315

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole-trimethoprim (oral) for 14 days
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pentamidine (intramuscular) for 14 days
Number of subjects: 25
Study: 30691177

Group type: EXPERIMENTAL
Intervention: Extremely randomized trees approach using precomputed features and data from the wrist sensor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Convolutional deep learning networks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of two sensors (pocket and wrist)
Number of subjects: 0
Study: 30259769

Group type: EXPERIMENTAL
Intervention: 10 mL of 2% lidocaine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 20 mL of 1% lidocaine
Number of subjects: 20
Study: 25774676

Group type: EXPERIMENTAL
Intervention: One hang-up visit
Number of subjects: 1811

Group type: EXPERIMENTAL
Intervention: Two hang-up visits
Number of subjects: 1811

Group type: COMPARATOR
Intervention: Control (no additional visits)
Number of subjects: 1811

Group type: EXPERIMENTAL
Intervention: All campaign nets hanging
Number of subjects: 1811
Study: 23505991

Group type: EXPERIMENTAL
Intervention: Six 30-min phone consultation sessions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Workshop-only condition (no additional contact)
Number of subjects: 20
Study: 21410922

Group type: EXPERIMENTAL
Intervention: Universal school-based intervention in social-emotional learning and literacy development
Number of subjects: 1184
Study: 19221594

Group type: EXPERIMENTAL
Intervention: Phase change material (PCM) sodium acetate trihydrate, applied for 28-31 days for ulcers ≤2 cm and 50-55 days for ulcers >2 cm.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Phase change material (PCM) sodium acetate trihydrate, applied for thermotherapy.
Number of subjects: 6
Study: 17584850

Group type: EXPERIMENTAL
Intervention: Bullard laryngoscope (Group BL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intubating Laryngeal Mask Airway (Group IL)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups (BL and ILMA)
Number of subjects: 62
Study: 15052193

Group type: EXPERIMENTAL
Intervention: Morphologically left ventricular reconditioning via pulmonary artery banding followed by an arterial switch operation and atrial reseptation
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Atrial switch operation and atrial reseptation
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Long-term follow-up
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Echocardiographic evaluation
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Age greater than 12 years
Number of subjects: 39
Study: 11300507

Group type: EXPERIMENTAL
Intervention: MDMA 100 mg as a single oral dose
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Drugwipe (immunochemical strip test)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: GC-MS for plasma and urine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: GC-MS for urine
Number of subjects: 2
Study: 8185149

Group type: EXPERIMENTAL
Intervention: Comprehensive discharge planning protocol implemented by nurse specialists
Number of subjects: 276

Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control group (standard discharge planning)
Number of subjects: 276
Study: 3070683

Group type: EXPERIMENTAL
Intervention: norfloxacin (400 mg) twice daily for 10 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: trimethoprim‐sulfamethoxazole (160‐800 mg) twice daily for 10 days
Number of subjects: 40
Study: 30341453

Group type: EXPERIMENTAL
Intervention: SC abatacept 125 mg/week plus methotrexate (MTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire-Disability Index
Number of subjects: 0
Study: 28484308

Group type: EXPERIMENTAL
Intervention: Mediterranean diet plus extra virgin olive oil (MeDiet+EVOO)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Mediterranean diet plus nuts (MeDiet+nuts)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Low-fat diet (LFD)
Number of subjects: 66
Study: 26429851

Group type: EXPERIMENTAL
Intervention: Extended-release niacin (ER-niacin)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 23874021

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (20 mg/wk)
Number of subjects: 25000

Group type: EXPERIMENTAL
Intervention: Interleukin-1β (IL-1β) inhibition (Canakinumab)
Number of subjects: 25000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25000
Study: 21931500

Group type: EXPERIMENTAL
Intervention: Carbohydrate-derived fulvic acid (CHD-FA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 18310377

Group type: EXPERIMENTAL
Intervention: Training in local hospitals
Number of subjects: 24

Group type: COMPARATOR
Intervention: Training at the simulation center
Number of subjects: 24

Group type: COMPARATOR
Intervention: Teamwork theory training
Number of subjects: 24
Study: 16781919

Group type: EXPERIMENTAL
Intervention: HIV educational video
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual practice with an HIV counselor
Number of subjects: 124
Study: 12876632

Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists for 3 months
Number of subjects: 360

Group type: COMPARATOR
Intervention: Vitamin K antagonists for 6 months
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Both treatment durations (3 months and 6 months)
Number of subjects: 360
Study: 10947753

Group type: EXPERIMENTAL
Intervention: Video-optical intubation stylet
Number of subjects: 45

Group type: COMPARATOR
Intervention: Malleable stylet
Number of subjects: 45
Study: 9058871

Group type: EXPERIMENTAL
Intervention: RV+ (initial defibrillation current flowing from active can/SVC coil to the RV coil)
Number of subjects: 22

Group type: COMPARATOR
Intervention: RV- (initial defibrillation current flowing from RV coil to active can/SVC)
Number of subjects: 22
Study: 8070990

Group type: EXPERIMENTAL
Intervention: Verbal method (routine calming words by dentist) plus BWS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Verbal method plus BWS and alpha relaxation tape
Number of subjects: 30

Group type: COMPARATOR
Intervention: Verbal method alone
Number of subjects: 30
Study: 3330116

Group type: EXPERIMENTAL
Intervention: 40 mg/die slow release nifedipine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31647124

Group type: EXPERIMENTAL
Intervention: Treatment response (continued-improvers)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Treatment response (halted-improvers)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Clinical remission cut-off score (≤27)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Symptom reduction score (≥50%)
Number of subjects: 465
Study: 30113476

Group type: EXPERIMENTAL
Intervention: Standard care plus postoperative pulmonary rehabilitation program
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 240
Study: 27410163

Group type: EXPERIMENTAL
Intervention: DN+PENS group
Number of subjects: 62

Group type: COMPARATOR
Intervention: DN group
Number of subjects: 62
Study: 25706266

Group type: EXPERIMENTAL
Intervention: Exposed acellular dermal matrix (ADM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no biomaterial)
Number of subjects: 30
Study: 23931044

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion (0.5 mmol/kg bolus followed by 0.2 mmol/kg/hour infusion)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sodium chloride infusion (placebo)
Number of subjects: 50
Study: 20494931

Group type: EXPERIMENTAL
Intervention: Allogeneic stem cell transplantation
Number of subjects: 341

Group type: COMPARATOR
Intervention: No donor (control group)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell transplantation
Number of subjects: 341

Group type: COMPARATOR
Intervention: High-dose cytarabine (control group)
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Intermediate/high risk cytogenetic abnormalities
Number of subjects: 341

Group type: EXPERIMENTAL
Intervention: Low risk cytogenetic characteristics
Number of subjects: 341
Study: 18468190

Group type: EXPERIMENTAL
Intervention: Smoking 2 regular cigarettes
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Smoking 2 mentholated cigarettes
Number of subjects: 42

Group type: COMPARATOR
Intervention: Smoking mentholated cigarettes
Number of subjects: 42
Study: 16980158

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.4 microg kg(‐1) h(‐1), n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline placebo (n = 14)
Number of subjects: 28
Study: 12785458

Group type: EXPERIMENTAL
Intervention: Tramadol (75 mg or 112.5 mg) plus Acetaminophen (650 mg or 975 mg)
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Tramadol (75 mg or 112.5 mg)
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Acetaminophen (650 mg or 975 mg)
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Ibuprofen (400 mg)
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Tramadol/Acetaminophen combination
Number of subjects: 1400
Study: 10687148

Group type: COMPARATOR
Intervention: Cohort 1: high-dose cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by peripheral blood stem cell infusion and granulocyte colony-stimulating factor at 10 micrograms/kg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cohort 2: CTCb plus rhIL-2 (2 x 10(6) IU/m2/day) for 4 days intravenously via continuous infusion after peripheral blood stem cell infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cohort 3: CTCb followed by infusion of autologous activated NK cells and rhIL-2 (2 x 10(6) IU/m2/day) for 4 days via continuous intravenous infusion
Number of subjects: 15
Study: 8567973

Group type: EXPERIMENTAL
Intervention: Low-dose (0.025 U/kg) infusion over 10 min
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Low-dose (0.025 U/kg) bolus injection
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-dose (0.050 U/kg) bolus injection
Number of subjects: 7
Study: 8225725

Group type: EXPERIMENTAL
Intervention: 2% topical minoxidil solution
Number of subjects: 294

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 294
Study: 2872054

Group type: EXPERIMENTAL
Intervention: Propranolol (8 mg i.v.)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pindolol (0.8 mg i.v.)
Number of subjects: 32
Study: 29538506

Group type: EXPERIMENTAL
Intervention: ET+NIV (Exercise Training with Non-Invasive Ventilation)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ET+Sham (Exercise Training with Placebo NIV)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (Standard Medical Treatment)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ET+NIV
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: ET+Sham
Number of subjects: 29
Study: 27116198

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 25168488

Group type: EXPERIMENTAL
Intervention: Stable background AD medication
Number of subjects: 4495

Group type: COMPARATOR
Intervention: Control-arm data (placebo and stable background AD medication)
Number of subjects: 4495
Study: 22224560

Group type: EXPERIMENTAL
Intervention: Usual support supplemented by the online parent information and support package
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual professional support
Number of subjects: 80
Study: 19674789

Group type: EXPERIMENTAL
Intervention: cediranib (RECENTIN™) at doses of ≤30 mg/day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: cediranib (RECENTIN™)
Number of subjects: 35
Study: 18279553

Group type: EXPERIMENTAL
Intervention: Plant stanol esters mixed with vegetable oil spreads (2 g/d)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sunflower oil spread without stanol ester
Number of subjects: 200
Study: 15752828

Group type: EXPERIMENTAL
Intervention: Virosomal vaccine (Epaxal)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Aluminum-adsorbed vaccine (Havrix 1440)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 111
Study: 12883493

Group type: EXPERIMENTAL
Intervention: peginterferon alfa‐2b 1.5 mcg per kg and ribavirin for 48 weeks
Number of subjects: 352

Group type: COMPARATOR
Intervention: interferon alfa‐2b 3 MU three times a week and ribavirin for 48 weeks
Number of subjects: 352
Study: 10583450

Group type: EXPERIMENTAL
Intervention: Vitamin E 100 IU daily, increased to 1600 IU daily
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8934240

Group type: EXPERIMENTAL
Intervention: Routine monthly changes of percutaneous feeding tubes
Number of subjects: 26

Group type: COMPARATOR
Intervention: prn changes of percutaneous feeding tubes
Number of subjects: 26
Study: 1875728

Group type: EXPERIMENTAL
Intervention: Low therapeutic dosage of methionyl‐human growth hormone (met‐hGH)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High therapeutic dosage of methionyl‐human growth hormone (met‐hGH)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Methionyl‐human growth hormone (met‐hGH) supplementation
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 6662147

Group type: EXPERIMENTAL
Intervention: Controlled release aminophylline (Phyllocontin)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Choline Theophyllinate
Number of subjects: 25
Study: 30061073

Group type: EXPERIMENTAL
Intervention: Upper-body resistance exercise training (RET) for 8 weeks, 3 sessions per week at 60-80% maximum force
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Upper-body resistance exercise training (RET)
Number of subjects: 20
Study: 29683408

Group type: EXPERIMENTAL
Intervention: Chewing gum (Group A; n = 15)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cold bottle (Group B; n = 20)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cold bottle + Chewing gum (Group C; n = 17)
Number of subjects: 52
Study: 26923616

Group type: EXPERIMENTAL
Intervention: Immediate auditory feedback therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Jittered auditory feedback therapy
Number of subjects: 34
Study: 25275520

Group type: EXPERIMENTAL
Intervention: Pomegranate fruit extract and galangal rhizome (Punalpin) tablets taken daily for three months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo tablets taken daily for three months
Number of subjects: 70
Study: 23478695

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 192
Study: 20484775

Group type: EXPERIMENTAL
Intervention: VFB(CP0) - Visual feedback of center of pressure displacements in real time
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: VFB(CP600) - Visual feedback of center of pressure displacements with a 600-ms delay
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: VFB(CP-CG600) - Visual feedback of center of pressure minus center of gravity displacements with a 600-ms delay
Number of subjects: 56

Group type: COMPARATOR
Intervention: Eyes open - Non-visual feedback condition
Number of subjects: 56
Study: 18824758

Group type: EXPERIMENTAL
Intervention: Radial artery grafting
Number of subjects: 561

Group type: COMPARATOR
Intervention: Saphenous vein grafting
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Overall graft occlusion
Number of subjects: 561
Study: 16189518

Group type: EXPERIMENTAL
Intervention: S-1 2-week administration followed by 1-week rest for 6 months (arm A)
Number of subjects: 102

Group type: COMPARATOR
Intervention: S-1 4-week administration followed by 2-week rest for 6 months (arm B)
Number of subjects: 102
Study: 12296461

Group type: EXPERIMENTAL
Intervention: Non-coated extracorporeal circuit
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Heparin-coated extracorporeal circuit
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 30
Study: 9951491

Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.2%
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 7498641

Group type: EXPERIMENTAL
Intervention: Mental stress
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Active relaxation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 22
Study: 2100969

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and levamisole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiotherapy combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Portal infusion of cytotoxic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil with leucovorin
Number of subjects: 0
Study: 7280636

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Clindamycin/Tobramycin
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study: 27530654

Group type: EXPERIMENTAL
Intervention: Stress management and lifestyle program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 28094477

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (1.5 mg/kg loading, 1.5 mg/kg/h infusion)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.5 µg/kg loading, 0.4 µg/kg/h infusion)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg loading, 1.5 mg/kg/h infusion) and dexmedetomidine (0.5 µg/kg loading, 0.4 µg/kg/h infusion)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 240
Study: 25927191

Group type: EXPERIMENTAL
Intervention: Interactive, predictors-based intervention delivered via the Internet
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Static informational web site
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Mailed sampler of hearing protectors
Number of subjects: 701

Group type: EXPERIMENTAL
Intervention: Combination of interventions
Number of subjects: 701
Study: 24200100

Group type: EXPERIMENTAL
Intervention: Integrative Treatment (IT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Therapeutic Acupuncture (TA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional Treatment (CT)
Number of subjects: 120
Study: 21905959

Group type: EXPERIMENTAL
Intervention: Powered‐assisted partial turbinectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mometasone furoate nasal spray
Number of subjects: 0
Study: 19289630

Group type: EXPERIMENTAL
Intervention: Gefitinib 250 mg/day
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Gefitinib 500 mg/day
Number of subjects: 486

Group type: COMPARATOR
Intervention: Methotrexate 40 mg/m2 intravenously weekly
Number of subjects: 486
Study: 17878265

Group type: EXPERIMENTAL
Intervention: Chest pain unit care
Number of subjects: 0
Study: 15235059

Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 186

Group type: COMPARATOR
Intervention: L‐DOPA
Number of subjects: 186
Study: 11230836

Group type: EXPERIMENTAL
Intervention: Quinapril (40 mg/day)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 9757880

Group type: EXPERIMENTAL
Intervention: ICSI candidates
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Azoospermic patients
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Oligospermic patients
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (100 fathers)
Number of subjects: 186
Study: 7917794

Group type: EXPERIMENTAL
Intervention: Fixed combination of atenolol (50 mg) and nifedipine (20 mg)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Nifedipine (20 mg) alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 102